Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Hamilton

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|April 16, 2014
Differential signaling by protease-activated receptors: implications for therapeutic targetingTejminder S Sidhu, Shauna L French, Justin R Hamilton
Expert Opinion on Drug Discovery|March 15, 2013
Antiplatelet therapy: present status and future prospectsJustin R Hamilton, Zane Kaplan, Shaun P Jackson, et al.
Journal of Thrombosis and Haemostasis : JTH|October 12, 2023
PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic miceNatasha M Setiabakti, Volga Tarlac, Pia Larsson, et al.
British Journal of Pharmacology|June 11, 2002
Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteriesJustin R Hamilton, James D Moffatt, James Tatoulis, et al.
Blood|September 25, 2003
Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiencyEric Camerer, Daniel N Duong, Justin R Hamilton, et al.
Thrombosis and Haemostasis|December 22, 2011
The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditionsHannah Lee, Sharelle A Sturgeon, Shaun P Jackson, et al.
Blood Reviews|December 4, 2014
Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agentShauna L French, Jane F Arthur, Huyen A Tran, et al.
Blood|October 18, 2002
Protection against thrombosis in mice lacking PAR3Ethan J Weiss, Justin R Hamilton, Katy E Lease, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanismsXiao Su, Eric Camerer, Justin R Hamilton, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosisErik R Vandendries, Justin R Hamilton, Shaun R Coughlin, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|April 16, 2014
Differential signaling by protease-activated receptors: implications for therapeutic targetingTejminder S Sidhu, Shauna L French, Justin R Hamilton
Expert Opinion on Drug Discovery|March 15, 2013
Antiplatelet therapy: present status and future prospectsJustin R Hamilton, Zane Kaplan, Shaun P Jackson, et al.
Journal of Thrombosis and Haemostasis : JTH|October 12, 2023
PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic miceNatasha M Setiabakti, Volga Tarlac, Pia Larsson, et al.
British Journal of Pharmacology|June 11, 2002
Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteriesJustin R Hamilton, James D Moffatt, James Tatoulis, et al.
Blood|September 25, 2003
Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiencyEric Camerer, Daniel N Duong, Justin R Hamilton, et al.
Thrombosis and Haemostasis|December 22, 2011
The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditionsHannah Lee, Sharelle A Sturgeon, Shaun P Jackson, et al.
Blood Reviews|December 4, 2014
Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agentShauna L French, Jane F Arthur, Huyen A Tran, et al.
Blood|October 18, 2002
Protection against thrombosis in mice lacking PAR3Ethan J Weiss, Justin R Hamilton, Katy E Lease, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanismsXiao Su, Eric Camerer, Justin R Hamilton, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosisErik R Vandendries, Justin R Hamilton, Shaun R Coughlin, et al.
Pageof 5